Fenwick represented Sutro Biopharma, Inc. on the deal.Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage oncology company, announced its strategic collaboration and licensing agreement with Astellas Pharma Inc….
Sutro Biopharma’s Strategic Collaboration with Astellas
